Medtronic plc (MDT) is a Medical - Devices company in the Healthcare sector, currently trading at $88.12. It has a SharesGrow Score of 69/100, indicating a above average investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of MDT = $119.62 (+35.7% from the current price, the stock appears undervalued). Analyst consensus target is MDT = $111 (+26.5% upside).
Valuation: MDT trades at a trailing Price-to-Earnings (P/E) of 24.4 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 3.36.
Financials: revenue is $33.5B, +1.2%/yr average growth. Net income is $4.7B, growing at +8.9%/yr. Net profit margin is 13.9% (healthy). Gross margin is 65.3% (+0 pp trend).
Balance sheet: total debt is $28.5B against $48.0B equity (Debt-to-Equity (D/E) ratio 0.59, moderate). Current ratio is 1.85 (strong liquidity). Debt-to-assets is 31.1%. Total assets: $91.7B.
Analyst outlook: 27 / 49 analysts rate MDT as buy (55%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value 47/100 (Partial), Growth 55/100 (Partial), Past 100/100 (Pass), Health 83/100 (Pass), Moat 86/100 (Pass), Future 58/100 (Partial), Income 55/100 (Partial).
